March 3rd 2019,
Kompo Green Inc. is a privately held pharmaceutical/nutraceutical company formed to commercialize Next Generation therapeutics, which uses a fusion of Eastern and Western medicine. Instead of a one directional treatment, we use a multi prong approach to health utilizing botanical-based formulations.
The Company holds the IP for several formulations targeting the following medical issues: Anxiety; Pain; Diabetes; TBI; and PTSD. The Company’s activities are focused exclusively on the development of treatments that are assessable, affordable, responsibly sourced, and clinically trialed on a diverse patient pool with low adverse effects.
We have been using cannabinoids in our formulations and trials successfully and adhere to all regulatory authorities in all links of the supply chain (growing, harvesting, manufacturing, and sourcing materials).
We consider ourselves a legacy company as we work with a retired and retiring doctors, universities and foreign entities that have formulations, they couldn’t bring to the market for various reasons (funding, supply chain issues, corporate greed, clinical trials, etc.) In this age of medical Renaissance, the culture has shifted from wanting quick results to wanting safe and efficient results.
Currently in trial and Orphan Drug status is our formulation for the treatment of Von Hippel-Lindau disease . It took many collaborations and perseverance in order to cross the blood brain barrier to treat such a hostile disease. Through our breakthrough approach we are able to off label and begin clinical trials of other therapies for similar diseases.
We have recently expanded into medical-grade foods.
Our focus is to create Next Generation Nutraceuticals, Pharmaceuticals, and Medical Foods that are affordable, assessable, and with minimal adverse, effects. We focus on a multi-prong approach to therapeutics instead of the typical western medicine mono approach.
Currently in clinical trials for the following:
5. TBI (Traumatic Brain Injury).
This Prolific-Fund.org and prolific-fund.com website and its affiliates (Kompo Green Inc., FOD Enterprises LLC, Botanalytics Inc.,HarvestMoonAgLLC.com) is not an offer to sell or a solicitation of an offer to buy securities and contains forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Results may differ materially from those implied or expressed by such forward-looking statements.
© 2014-2021 FOD Enterprises LLC